Showing results (401-410 of 431) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.
Diabetes & Metabolism|June 1, 1997
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study GroupB Guerci, D Durain, H Leblanc, et al.
Diabetologia|November 10, 2009
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patientsE Vandemeulebroucke, B Keymeulen, K Decochez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Diabetes, Obesity & Metabolism|October 10, 2015
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesG Fulcher, D R Matthews, V Perkovic, et al.
Diabetes Care|August 11, 2000
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes RegistryK Decochez, B Keymeulen, G Somers, et al.
Parasitology Research|October 18, 2018
An in vitro approach to evaluate the nutraceutical value of plant foliage against Haemonchus contortusG S Castañeda-Ramírez, M Rodríguez-Labastida, G I Ortiz-Ocampo, et al.
Oncogene|August 16, 2011
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammationE N Gurzov, J Barthson, I Marhfour, et al.
Clinical and Experimental Immunology|May 25, 2007
Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetesI Truyen, J De Grijse, I Weets, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Pageof 44